Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$227,244
+$5,757 QoQ
Shares Held
1,450
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,260
of 1,603 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BBR PARTNERS, LLC holds $25,619,055 across 7 Drug Manufacturers - General names. NVS ranks #7 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
53,615 | $13,491,678 | |
| 2 | JNJ |
Johnson & Johnson
|
27,913 | $7,089,064 | |
| 3 | AMGN |
Amgen Inc
|
5,580 | $2,020,629 | |
| 4 | LLY |
ELI LILLY & Co
|
1,523 | $1,826,732 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
8,889 | $512,184 | |
| 6 | PFE |
Pfizer Inc
|
18,751 | $451,524 | |
| 7 | NVS |
Novartis AG
This page
|
1,450 | $227,244 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $227,244 | 1,450 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $221,487 | 1,450 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $323,029 | 2,343 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $300,466 | 2,343 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $310,390 | 2,565 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $285,946 | 2,565 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $249,600 | 2,565 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $295,026 | 2,565 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $273,069 | 2,565 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $692,393 | 7,158 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $423,973 | 4,199 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $282,050 | 2,769 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $279,419 | 2,769 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $254,748 | 2,769 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $232,696 | 2,565 | Shares | Sole | 2023-02-13 | |
| 2022-06-30 | $216,819 | 2,565 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $225,078 | 2,565 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $286,289 | 3,273 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $209,765 | 2,565 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $234,030 | 2,565 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $258,662 | 3,026 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $285,934 | 3,028 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $263,314 | 3,028 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $799,685 | 9,156 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,248,375 | 15,141 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||